Hypertension is one of the most important risk factors for cardiovascular events, which is strongly related with endothelial dysfunction. Endothelial function assessed by flow-mediated dilation (FMD) is 3.2% lower in hypertensives than in normotensives. The negative balance between damage and regeneration of endothelial cells indicated by a high number of circulating endothelial microparticles (EMP) and reduced levels of endothelial progenitor cells (EPC) is predictor of cardiovascular events in hypertensives. Thus, therapies able to positively influence endothelial function are important to […]